2090-3111

Prostate Cancer

Hindawi Limited

View prefix report (10.1155)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 95 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact95 DOIs
2

Add abstracts to 15 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact15 DOIs
3

Deposit reference lists for 11 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact11 DOIs

DOIs for this ISSN

Showing the top 5 of 210 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Relationship of Dietary Intake of Omega-3 and Omega-6 Fatty… (10.1155/2012/826254)
Abstract ORCID
78.99 37
2 Racial Disparities in Prostate Cancer Incidence, Biochemical… (10.1155/2011/716178)
Abstract References
57.31 13
3 Global Patterns of Prostate Cancer Incidence, Aggressiveness… (10.1155/2013/560857)
ORCID
56.68 184
4 Castration-Resistant Prostate Cancer: Mechanisms, Targets, a… (10.1155/2012/327253)
ORCID
48.49 86
5 Vitamin D Levels in Subjects with Prostate Cancer Compared t… (10.1155/2012/524206)
Abstract ORCID
47.71 8
6 Prostate Cancer Incidence Rates in Africa (10.1155/2011/947870)
ORCID
45.15 63
7 Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostat… (10.1155/2012/128965)
ORCID
43.31 53
8 Systematic Review of the Relationship between Acute and Late… (10.1155/2015/624736)
ORCID
41.09 43
9 Circulating MicroRNAs as Biomarkers of Prostate Cancer: The… (10.1155/2013/539680)
ORCID
40.84 42
10 Epigenetics in Prostate Cancer (10.1155/2011/580318)
ORCID
40.58 41
11 Hydrogen Sulfide Signaling Axis as a Target for Prostate Can… (10.1155/2016/8108549)
ORCID
40.32 40
12 Factors Implicated in Radiation Therapy Failure and Radiosen… (10.1155/2012/593241)
ORCID
39.78 38
13 Long-Term (10-Year) Gastrointestinal and Genitourinary Toxic… (10.1155/2012/853487)
Abstract
39.49 37
14 Dissecting Major Signaling Pathways throughout the Developme… (10.1155/2013/920612)
ORCID
39.21 36
15 A Retrospective Study on Pathologic Features and Racial Disp… (10.1155/2011/239460)
ORCID
38.91 35
16 Rectourinary Fistula after Radical Prostatectomy: Review of… (10.1155/2011/629105)
ORCID
38.60 34
17 Review of Small Cell Carcinomas of the Prostate (10.1155/2011/543272)
ORCID
38.29 33
18 Hypofractionated Proton Boost Combined with External Beam Ra… (10.1155/2012/654861)
ORCID
38.29 33
19 Systematic Review of Focal Prostate Brachytherapy and the Fu… (10.1155/2016/4754031)
ORCID
38.29 33
20 Metastasis Update: Human Prostate Carcinoma Invasion via Tub… (10.1155/2011/249290)
ORCID
36.93 29
21 Cryotherapy for Primary Treatment of Prostate Cancer: Interm… (10.1155/2014/571576)
ORCID
36.56 28
22 Erratum to “Primary Zonal High Intensity Focused Ultrasound… (10.1155/2014/640859)
Abstract References ORCID
35.78 2
23 Advances in Robotic-Assisted Radical Prostatectomy over Time (10.1155/2013/902686)
ORCID
34.95 24
24 Prostate Cancer Incidence and Mortality in Barbados, West In… (10.1155/2011/565230)
ORCID
34.51 23
25 Analysis of Preoperative Detection for Apex Prostate Cancer… (10.1155/2013/705865)
ORCID
34.51 23
26 Cellular Plasticity in Prostate Cancer Bone Metastasis (10.1155/2015/651580)
ORCID
34.04 22
27 Androgen Metabolism Gene Polymorphisms, Associations with Pr… (10.1155/2012/798634)
ORCID
33.56 21
28 Fortifying the Treatment of Prostate Cancer with Physical Ac… (10.1155/2016/9462975)
ORCID
33.06 20
29 Proliferative Tumor Doubling Times of Prostatic Carcinoma (10.1155/2011/301850)
ORCID
32.53 19
30 Current Challenges in Development of Differentially Expresse… (10.1155/2012/640968)
ORCID
32.53 19
31 Does Statin or ASA Affect Survival When Prostate Cancer Is T… (10.1155/2014/184297)
ORCID
32.53 19
32 Role of Heparan Sulfate 2-O-Sulfotransferase in Prostate Can… (10.1155/2011/893208)
ORCID
31.97 18
33 Prognostic Factors for the Development of Biochemical Recurr… (10.1155/2011/485189)
ORCID
31.38 17
34 Salvage Brachytherapy for Biochemically Recurrent Prostate C… (10.1155/2016/9561494)
ORCID
31.38 17
35 Prostate Intrafraction Translation Margins for Real-Time Mon… (10.1155/2012/130579)
ORCID
30.76 16
36 Intake of Grains and Dietary Fiber and Prostate Cancer Aggre… (10.1155/2012/323296)
ORCID
30.76 16
37 Emerging Molecularly Targeted Therapies in Castration Refrac… (10.1155/2013/981684)
ORCID
30.76 16
38 Prostate Radiotherapy in the Era of Advanced Imaging and Pre… (10.1155/2016/4897515)
ORCID
30.76 16
39 Erratum to “Prostate Cancer in South Africa: Pathology Based… (10.1155/2014/391257)
Abstract References
30.10 3
40 Prostate Cancer in South Africa: Pathology Based National Ca… (10.1155/2014/419801)
ORCID
30.10 15
41 Burden of Illness in Prostate Cancer Patients with a Low-to-… (10.1155/2014/472949)
ORCID
30.10 15
42 Analysis of Prostate Cancer Susceptibility Variants in South… (10.1155/2015/465184)
ORCID
30.10 15
43 The Single-Knot Running Vesicourethral Anastomosis after Min… (10.1155/2016/1481727)
ORCID
30.10 15
44 Assessment of the Performance of Magnetic Resonance Imaging/… (10.1155/2016/3794738)
ORCID
30.10 15
45 Single High Intensity Focused Ultrasound Session as a Whole… (10.1155/2014/186782)
ORCID
29.40 14
46 Emerging Putative Biomarkers: The Role of Alpha 2 and 6 Inte… (10.1155/2012/298732)
ORCID
28.65 13
47 Incidentally Found Prostate Cancer and Influence on Overall… (10.1155/2012/690210)
ORCID
28.65 13
48 Evolving Paradigm of Radiotherapy for High-Risk Prostate Can… (10.1155/2016/2420786)
ORCID
28.65 13
49 Effect of Zoledronic Acid on Bone Mineral Density in Men wit… (10.1155/2011/176164)
ORCID
27.85 12
50 First Danish Single-Institution Experience with Radical Pros… (10.1155/2011/236357)
ORCID
27.85 12